SBIR Funding

NIH/NCI SBIR Phase I

SBIR Contract HHSN261201200048C (Paul Henderson, PI)

Active: 09/28/10-6/30/12
Phase 0 Microdosing Diagnostics Clinical Trial
The goal of this project is to determine the cut point in microdose-induced
carboplatin-DNA adducts that stratifies responders from nonresponders.
$200K

 

NIH/NCI SBIR Phase II

SBIR Contract HHSN261201200048C (Paul Henderson, PI)

Active: 09/28/12-9/27/14
Phase 0 Microdosing Diagnostics Clinical Trial
The goal of this project is to determine the cut point in microdose-induced carboplatin-DNA adducts that stratifies responders from nonresponders.
$1.5M

 

NIH/NCI SBIR Phase I

SBIR Contract HHSN261201200084C (Paul Henderson, PI)

Active: 09/21/12-6/20/13
Oxaliplatin Microdosing Clinical Trial
The goal of this trial is to carry out a Phase II clinical trial of breast cancer patients treated with oxaliplatin while simultaneously developing a companion
diagnostic for predicting which patients will respond.
$200K